| Average Maternal-Newborn Medicaid Payment for Study Population with the Hem-Avert Device (Investigational Group) |
| Type of birth |
No. of patients |
Avg. insurer payment ($) |
Total payment for group ($) |
| Cesarean |
6 |
13,327 |
79,962 |
| Vaginal |
44 |
9,002 |
396,088 |
| Total Medicaid Payment for Investigational Group: $476,050 |
| Average Medicaid Payment per Patient: $9,521 |
|
| Average Maternal-Newborn Medicaid Payment for Study Population without the Hem-Avert Device (Control Group) |
| Type of birth |
No. of patients |
Avg. insurer payment ($) |
Total payment for group ($) |
| Cesarean |
19 |
13,327 |
253,213 |
| Vaginal |
29 |
9,002 |
261,058 |
| Total Medicaid Payment for Control Group: $514,271 |
| Average Medicaid Payment per Patient: $10,714 |
|
| Table 4: Potential Cost Offsets from Use of the Hem-Avert Device–Medicaid. |
